Choksi Laboratories Ltd. (BSE: 526546) is an Indore, Madhya Pradesh-based company in the Consulting Services industry. With a market capitalisation of ₹137 Cr, it ranks #2,980 by market cap among the 6,197 Indian listed companies on FinBizNet, and #10 of 30 in Consulting Services. At ₹198.75 (as of 16 Nov 2026), the share price is 12.8% below its 52-week high of ₹227.90 and 142.8% above its 52-week low of ₹81.85. The share price is up 39.4% over one year and up 68.4% over three months.
| Current Price | ₹198.75 |
|---|---|
| Market Cap | ₹137 Cr |
| BSE Code | 526546 |
| Sector | Industrials > Commercial and Professional Services > Professional Services |
| Sub-Industry | Research and Consulting Services > Consulting Services |
| P/E Ratio | 69.5 |
| Return on Equity | 7.99% |
| Return on Assets | 4.61% |
| 52-Week Range | ₹81.85 – ₹227.90 |
| 1-Year Price Change | +39.4% |
| 3-Month Price Change | +68.4% |
| Beta (1Y) | 0.24 |
| Headquarters | Indore, Madhya Pradesh |
| Website | www.choksilab.com |
Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. Its contract laboratory services include pharmaceutical, food and beverages, soil and water, chemical, and construction material analysis. The company’s instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. It also offers environment management, laboratory set-up and management, waste water management, and air pollution monitoring services. In addition, the company provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, and auditing. Further, it offers assaying and hallmarking services for gold and silver. The company serves the pharmaceuticals, consumer products,
1. Analysis and Testing-This segment provides contract testing and analytical services.
1. Analysis and Testing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| L&T Technology Services Ltd (Ltts) | ₹44,849 Cr | 36.9 | 19.54% | ₹3,040 Cr | +3.9% |
| International Gemological Institute Limited | ₹18,559 Cr | 33.6 | 47.80% | ₹398 Cr | +21.9% |
| Central Mine Planning & Design Institute Ltd (CMPDI) | ₹13,769 Cr | 22.4 | 28.36% | ₹593 Cr | — |
| Latent View Analytics Limited | ₹4,366 Cr | 22.1 | 12.17% | ₹294 Cr | -52.3% |
| Emudhra Limited | ₹2,977 Cr | 27.8 | 13.26% | ₹207 Cr | -43.7% |
| Pacheli Industrial Finance Ltd | ₹1,550 Cr | 16,500 | 0.01% | ₹0 Cr | +5.8% |
| Qualitek Labs Limited | ₹641 Cr | 44.4 | — | — | +36.7% |
| Secmark Consultancy Ltd | ₹161 Cr | 64 | 11.70% | ₹12 Cr | +31.9% |
| Choksi Laboratories Ltd. | ₹137 Cr | 69.5 | 7.99% | — | +39.4% |
Listed by market capitalisation. Ratios are shown for context only.
Choksi Laboratories Ltd. is trading at ₹198.75, with a market capitalisation of ₹137 Cr.
Choksi Laboratories Ltd. operates in the Industrials > Commercial and Professional Services > Professional Services space (Research and Consulting Services > Consulting Services).
Choksi Laboratories Ltd. has a P/E of 69.5 and a return on equity of 7.99%.
Choksi Laboratories Ltd. is listed on the BSE under the scrip code 526546.
Choksi Laboratories Ltd.'s share price is up 39.4% over one year and up 68.4% over three months. Its 52-week range is ₹81.85 to ₹227.90.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.